ENDRA Life Sciences NDRAU 深 沪
等待开盘 07-01 09:30:00 美东时间
4.50
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.50
- 总市值 1490.87万
- 52周最高 5.59
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.01
- 委 比 0.00%
- 总股本 331.30万
- 历史最高 5.59
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.01
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ENDRA Life Sciences Plans Merger Creating Noble Africa Helium Platform
ENDRA Life Sciences ( ($NDRA) ) has shared an announcement. On June 25, 2026, A...
06-25 21:57
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
<p>Noble Africa LLC, a subsidiary of ASP Isotopes Inc., will merge with a subsidiary of ENDRA Life Sciences Inc. in a transaction expected to create Noble Africa Inc., a Nasdaq-listed company focused on Renergen’s Virginia Gas helium project. The merger, along with a concurrent private placement targeting $50 million in gross proceeds, aims to provide capital and market access for project development. ASP Isotopes will own approximately 89% of th...
06-25 13:30
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.
06-01 20:43
ENDRA Life Sciences Announces Strategic Private Placement Financing
The latest announcement is out from ENDRA Life Sciences ( ($NDRA) ). On May 27,...
05-28 18:37
ENDRA Life Sciences prices $3.8 million private placement at $6.57 per share with warrants
ENDRA Life Sciences prices $3.8 million private placement at $6.57 per share with warrants ENDRA Life Sciences entered a private placement to sell 578,387 shares of common stock and/or prefunded warrants to an accredited investor. The deal includes common warrants to buy up to 1,156,774 shares at US
05-28 18:08
ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from
05-18 20:04
ENDRA Life Sciences Reports Multi-Site Validation And MRI-Level Accuracy Of TAEUS Liver Device
The analysis combined data from 64 patients in the U.S. and Canada, including an external validation site in London, Ontario, across independent operators and patient populations. TAEUS Liver's thermoacoustic fat
05-14 20:09
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk
ENDRA Life Sciences ( ($NDRA) ) just unveiled an update. ENDRA Life Sciences di...
04-21 20:37
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
04-08 01:30
